The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).
 
Panagiota Economopoulou
No Relationships to Disclose
 
Nikolaos Spiridon Spathas
No Relationships to Disclose
 
George Papaxoinis
No Relationships to Disclose
 
Maria Anastasiou
No Relationships to Disclose
 
Maria Gkotzamanidou
No Relationships to Disclose
 
Ioannis Kotsantis
No Relationships to Disclose
 
Niki Gavrielatou
No Relationships to Disclose
 
Nikolaos Oikonomopoulos
No Relationships to Disclose
 
Euthymios Kirodimos
No Relationships to Disclose
 
Elena Mihal Vagia
No Relationships to Disclose
 
George Kavourakis
No Relationships to Disclose
 
Amanda Psyrri
Honoraria - Bayer; Bristol-Myers Squibb; Genesis Pharmaceuticals; Merck Serono; MSD Oncology; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pfizer
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Roche